Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyiv P Shupyk Medical AcademyfiledCriticalKyiv P Shupyk Medical Academy
Priority to UA20031211453ApriorityCriticalpatent/UA67682A/en
Publication of UA67682ApublicationCriticalpatent/UA67682A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The method for preventing intranatal infection of the fetus in HIV-infected women upon the delivery via the maternal passages provides for using antiretroviral drugs, Retrovir 300 mg each 3 hours or Nevirapin 200 mg once at the beginning of the labor. Each two hours the maternal passages are treated with 0.002% solution of chlorohexidin. In addition, before the labor Misoprostol in injected into the posterior fornix of the vagina at a dose of 50 mg. If necessary, Misoprostol in injected once again in 4 hours.
UA20031211453A2003-12-122003-12-12Method for preventing intranatal infection of fetus in hiv-infected women upon delivery via maternal passages
UA67682A
(en)
PHYSIOLOGICALLY ACTIVE PEG-CONJUGATE OF a-INTERFERON, A METHOD FOR PREPARING THE SAME, A PHARMACEUTICAL COMPOSITION BASED THEREON AND A METHOD FOR TREATMENT OR PROPHYLAXIS OF IMMUNOMODULAR DISEASES
USE OF PARATORMONE, ITS BIOLOGICALLY ACTIVE FRAGMENTS AND RELATED PEPTIDES, FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS USEFUL IN THE PREVENTION AND THERAPY OF ABORTION AND PRE-TERM BIRTH AND IN GENERAL FOR THE TREATMENT OF THE MANAGEMENT